Skip to main content
. 2017 Jun 12;4:51–56. doi: 10.1016/j.ctro.2017.05.001

Fig. 3.

Fig. 3

5-year PFS (A) and OS (B) comparing patient’s Hgb status throughout treatments: Hgb levels >115 g/L both pre- and during-treatment (HH group), normal pre-treatment and low during treatment (HL group), low pre-treatment and normal during treatment (LH group), and low both pre- and during-treatment (LL group).